Conformal Medical, Inc. announced today, the next-generation CLAAS® AcuFORM™ Left Atrial Appendage Occlusion (LAAO) System will be highlighted during the 2024 Transcatheter Cardiovascular Therapeutics ...

Chukwudi Obiagwu and Cardiac Electrophysiologist Dr. Darpan Kumar, the Left Atrial Appendage Occlusion, or LAAO, procedure reduces the risk of stroke without the need for costly blood thinners.

AuriGen Medical, a medical device company specializing in left atrial appendage occlusion (LAAO) technology, today announced ...

Study will assess the Company's Next-Generation device under Intracardiac Echocardiography (ICE) imaging for Left Atrial Appendage Occlusion (LAAO) procedures. NASHUA, N.H., Oct. 1, 2024 ...

Study will assess the Company's Next-Generation device under Intracardiac Echocardiography (ICE) imaging for Left Atrial Appendage Occlusion (LAAO) procedures. NASHUA, N.H., Oct. 1, 2024 ...

The atrial appendage occluder market is on a remarkable growth trajectory, with a projected market size of USD 983.5 million in 2023, expected to surge to USD 8,193.0 million by 2033. This growth is ...